Zymeworks Inc. (35)
Browse by Contract Category
Contracts
-
Open Market Sale AgreementSM, dated October 21, 2022, by and between Zymeworks Inc. and Jefferies LLC
(Filed With SEC on October 21, 2022)
-
Restated and Amended Transaction Agreement, dated August 18, 2022, by and among Zymeworks, Parent, Callco, and ExchangeCo
(Filed With SEC on August 19, 2022)
-
Employment Agreement by and between the Company, Zymeworks Biopharmaceuticals Inc. and Paul Moore, dated July 18, 2022
(Filed With SEC on August 4, 2022)
-
Third Amendment to Collaboration and Cross License Agreement, effective June 6, 2022, by and between the Company and Daiichi Sankyo Co., Ltd
(Filed With SEC on August 4, 2022)
-
Notice of Assignment of Lease, dated January 1, 2022 from 5
(Filed With SEC on August 4, 2022)
-
Lease Amending Agreement, dated April 1, 2022, by and between the Company and 130 E 4th Partnership
(Filed With SEC on August 4, 2022)
-
Transaction Agreement, dated July 14, 2022, by and among Zymeworks, Parent, Callco, and ExchangeCo
(Filed With SEC on July 15, 2022)
-
Resolutions of the Board of Directors of Zymeworks, Inc. (incorporated by reference to Exhibit A of Exhibit 4.1 hereto)
(Filed With SEC on June 10, 2022)
-
Zymeworks Inc. Executive Incentive Compensation Plan
(Filed With SEC on March 9, 2022)
-
Amended and Restated Employment Agreement by and between the Company and Christopher Astle, effective February 24, 2022
(Filed With SEC on February 25, 2022)
-
Letter, dated November 9, 2021, from the
(Filed With SEC on February 24, 2022)
-
Separation and Release Agreement by and between the Company and James Priour, dated
(Filed With SEC on February 24, 2022)
-
Specimen common share certificate
(Filed With SEC on February 24, 2022)
-
Form of Pre-Funded Warrant to Purchase Common Shares
(Filed With SEC on January 27, 2022)
-
Underwriting Agreement dated January 26, 2022
(Filed With SEC on January 27, 2022)
-
Promotion Letter from the Company to Neil Klompas, dated January 5, 2022
(Filed With SEC on January 5, 2022)
-
Zymeworks Inc. Inducement Stock Option and Equity Compensation Plan
(Filed With SEC on January 5, 2022)
-
Separation Agreement and Release by and between the Company and Ali Tehrani, dated January 5, 2022
(Filed With SEC on January 5, 2022)
-
Employment Agreement by and between the Company and Kenneth Galbraith, dated January 5, 2022
(Filed With SEC on January 5, 2022)
-
Amendment No. 1 to the Open Market Sale AgreementSM, dated October 1, 2021, by and between Zymeworks Inc. and Jefferies LLC
(Filed With SEC on October 1, 2021)
-
Letter, dated May 16, 2021, from the Registrant to Neil Josephson
(Filed With SEC on August 4, 2021)
-
Employment Agreement, effective April 29, 2019, by and between the Registrant and Neil Josephson
(Filed With SEC on August 4, 2021)
-
Letter, dated March 3, 2021, from the Registrant to James Priour
(Filed With SEC on May 5, 2021)
-
Employment Agreement, effective April 1, 2020, by and between the Registrant and James Priour
(Filed With SEC on May 5, 2021)
-
First Amendment to Collaboration Agreement, dated May 25, 2020, by and between Zymeworks Inc. and BeiGene, Ltd
(Filed With SEC on August 5, 2020)
-
Third Amendment to Collaboration Agreement, dated June 22, 2020, by and between Zymeworks Inc., Celgene Corporation and Celgene Alpine Investment Co. LLC
(Filed With SEC on August 5, 2020)
-
Zymeworks Amended and Restated Stock Option and Equity Compensation Plan
(Filed With SEC on May 7, 2020)
-
Registration Rights Agreement dated March 16, 2020, by and among Zymeworks Inc., Baker Brothers Life Sciences, L.P. and 667, L.P
(Filed With SEC on March 16, 2020)
-
Employment Agreement effective October 14, 2019, by and between the Registrant and Kathryn ODriscoll
(Filed With SEC on March 2, 2020)
-
Description of Capital Stock
(Filed With SEC on March 2, 2020)
-
Form of Pre-Funded Warrant to Purchase Common Shares
(Filed With SEC on January 24, 2020)
-
Underwriting Agreement dated January 22, 2020
(Filed With SEC on January 24, 2020)
-
Open Market Sale AgreementSM, dated November 5, 2019, between Zymeworks Inc. and Jefferies LLC
(Filed With SEC on November 6, 2019)
-
Employment Agreement effective September 17, 2018, by and between the Registrant and Anthony Polverino
(Filed With SEC on March 6, 2019)
-
Indenture of Lease dated as of January 25, 2019, by and between 5th & Main Partnership and Zymeworks Inc
(Filed With SEC on March 6, 2019)